Amunix Announces Exclusive Agreements With Naia to Develop GLP-1 and GLP-2 XTEN Products
MOUNTAIN VIEW, CA--(Marketwired - Jan 5, 2015) - Amunix Operating Inc. (Amunix), a leader in the field of protein half-life extension, today announced a research and development partnership with Naia Limited (Naia), an international drug development company that employs an...